Clinical Outcomes and Disease Management for Patients with Paroxysmal Nocturnal Haemoglobinuria in China: Results from a Real-World Study
Abstract Background Paroxysmal nocturnal haemoglobinuria (PNH) is a chronic haematological disorder caused by uncontrolled complement activation, leading to intravascular haemolysis, indicated by increased lactate dehydrogenase levels (LDH). Standard-of-care complement factor 5 inhibitors have only...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Adis, Springer Healthcare
2025-08-01
|
| Серии: | Drugs - Real World Outcomes |
| Online-ссылка: | https://doi.org/10.1007/s40801-025-00512-y |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
